Literature DB >> 21692914

Two recessive intermediate Charcot-Marie-Tooth patients with GDAP1 mutations.

Ki W Chung1, Young S Hyun, Hae J Lee, Hwa-Kyoung Jung, Heasoo Koo, Jeong H Yoo, Sang-Beom Kim, Chan I Park, Han N Kim, Byung-Ok Choi.   

Abstract

Various phenotypes have been reported in Charcot-Marie-Tooth (CMT) disease carrying mutations in the ganglioside-induced differentiation-associated protein 1 (GDAP1) gene. Here, we report two recessive intermediate Charcot-Marie-Tooth (RI-CMT) patients with GDAP1 missense mutations: a His256Arg homozygous mutation (c.767A>G + c.767A>G) and compound mutations of heterozygous Pro111His (c.332C>A) and Val219Gly (c.656T>G). The Pro111His and Val219Gly are unreported mutations, but the His256Arg was previously reported. In both patients, histopathological findings showed well-documented features of mixed demyelinating and axonal neuropathies, and nerve conduction velocities fall in the intermediate range. In addition, the patterns of fatty substitutions in leg magnetic resonance imaging (MRI) were different by the mutation sites within the same GDAP1 gene.
© 2011 Peripheral Nerve Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692914     DOI: 10.1111/j.1529-8027.2011.00329.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  8 in total

Review 1.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

2.  WES homozygosity mapping in a recessive form of Charcot-Marie-Tooth neuropathy reveals intronic GDAP1 variant leading to a premature stop codon.

Authors:  Marion Masingue; Jimmy Perrot; Robert-Yves Carlier; Guenaelle Piguet-Lacroix; Philippe Latour; Tanya Stojkovic
Journal:  Neurogenetics       Date:  2018-02-02       Impact factor: 2.660

3.  Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.

Authors:  Pukar Singh Pakhrin; Yongzhi Xie; Zhengmao Hu; Xiaobo Li; Lei Liu; Shunxiang Huang; Binghao Wang; Zihan Yang; Jiejun Zhang; Xin Liu; Kun Xia; Beisha Tang; Ruxu Zhang
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

4.  Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C.

Authors:  Samuel M Lee; Di Sha; Anum A Mohammed; Seneshaw Asress; Jonathan D Glass; Lih-Shen Chin; Lian Li
Journal:  Hum Mol Genet       Date:  2013-01-28       Impact factor: 6.150

5.  A compound heterozygous mutation in HADHB gene causes an axonal Charcot-Marie-tooth disease.

Authors:  Young Bin Hong; Ja Hyun Lee; Jin-Mo Park; Yu-Ri Choi; Young Se Hyun; Bo Ram Yoon; Jeong Hyun Yoo; Heasoo Koo; Sung-Chul Jung; Ki Wha Chung; Byung-Ok Choi
Journal:  BMC Med Genet       Date:  2013-12-05       Impact factor: 2.103

6.  Clinical and Neuroimaging Features in Charcot-Marie-Tooth Patients with GDAP1 Mutations.

Authors:  Hyun Su Kim; Hye Jin Kim; Soo Hyun Nam; Sang Beom Kim; Yu Jin Choi; Kyung Suk Lee; Ki Wha Chung; Young Cheol Yoon; Byung Ok Choi
Journal:  J Clin Neurol       Date:  2021-01       Impact factor: 3.077

7.  One PMP22/MPZ and Three MFN2/GDAP1 Concomitant Variants Occurred in a Cohort of 189 Chinese Charcot-Marie-Tooth Families.

Authors:  Yongzhi Xie; Zhiqiang Lin; Xiaobo Li; Lei Liu; Shunxiang Huang; Huadong Zhao; Binghao Wang; Wanqian Cao; Zhengmao Hu; Jifeng Guo; Lu Shen; Beisha Tang; Ruxu Zhang
Journal:  Front Neurol       Date:  2022-01-28       Impact factor: 4.003

8.  Identification and functional characterization of novel GDAP1 variants in Chinese patients with Charcot-Marie-Tooth disease.

Authors:  Cong-Xin Chen; Jia-Qi Li; Hai-Lin Dong; Gong-Lu Liu; Ge Bai; Zhi-Ying Wu
Journal:  Ann Clin Transl Neurol       Date:  2020-11-02       Impact factor: 5.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.